Lee, V.K., Lee, T., Ghosh, A., Saha, T., Bais, M.V., Bharani, K.K., Chag, M., Parikh, K., Bhatt, P., Namgung, B., Venkataramanan, G., Agrawal, A., Sonaje, K., Mavely, L., Sengupta, S., Mashelkar, R.A., Jang, H.L., 2024. An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy. Proc. Natl. Acad. Sci. U.S.A. 121, e2316170121. https://doi.org/10.1073/pnas.2316170121.
1. Reed ER, Jankowski SA, Spinella AJ, Noonan V, Haddad R, Nomoto K, Matsui J,Bais MV, Varelas X, Kukuruzinska MA, Monti S. beta-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer. Transl Res. 2023;260:46-60. Epub 2023/06/24. doi: 10.1016/j.trsl.2023.05.007. PubMed PMID: 37353110.
2. Alhousami T, Diny M, Ali F, Shin J, Kumar G, Kumar V, Campbell JD, Noonan V, Hanna GJ, Denis GV, Monti S, Kukuruzinska MA, Varelas X,Bais MV. Inhibition of LSD1 Attenuates Oral Cancer Development and Promotes Therapeutic Efficacy of Immune Checkpoint Blockade and YAP/TAZ Inhibition. Mol Cancer Res. 2022;20(5):712-21. Epub 2022/02/03. doi: 10.1158/1541-7786.MCR-21-0310. PubMed PMID: 35105672; PMCID: PMC9081163.
3. Joshi VG, Chindera K,Bais MV, Sajjanar B, Tiwari AK, Kumar S. Novel peptide (RATH) mediated delivery of peptide nucleic acids for antiviral interventions. Appl Microbiol Biotechnol. 2021;105(18):6669-77. Epub 2021/08/25. doi: 10.1007/s00253-021-11502-9. PubMed PMID: 34427763.
4. Tashkandi MM, Alsaqer SF, Alhousami T, Ali F, Wu YC, Shin J, Mehra P, Wolford LM, Gerstenfeld LC, Goldring MB,Bais MV. LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilage. Sci Rep. 2020;10(1):20179. Epub 2020/11/21. doi: 10.1038/s41598-020-77178-9. PubMed PMID: 33214607; PMCID: PMC7678826.
5. Chandler KB, Alamoud KA, Stahl VL, Nguyen BC, Kartha VK,Bais MV, Nomoto K, Owa T, Monti S, Kukuruzinska MA, Costello CE. beta-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma. Mol Omics. 2020;16(3):195-209. Epub 2020/03/24. doi: 10.1039/d0mo00009d. PubMed PMID: 32203567; PMCID: PMC7299767.
6. Tashkandi M, Ali F, Alsaqer S, Alhousami T, Cano A, Martin A, Salvador F, Portillo F, L CG, Goldring MB,Bais MV. Lysyl Oxidase-Like 2 Protects against Progressive and Aging Related Knee Joint Osteoarthritis in Mice. Int J Mol Sci. 2019;20(19). Epub 2019/10/02. doi: 10.3390/ijms20194798. PubMed PMID: 31569601; PMCID: PMC6801581.
7. Bais MV. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma. J Dent Res. 2019;98(3):268-76. Epub 2019/01/08. doi: 10.1177/0022034518816947. PubMed PMID: 30615537; PMCID: PMC6385352.
8. Trackman PC,Bais MV. Measurement of lysyl oxidase activity from small tissue samples and cell cultures. Methods Cell Biol. 2018;143:147-56. Epub 2018/01/10. doi: 10.1016/bs.mcb.2017.08.009. PubMed PMID: 29310775.
9. Kartha VK, Alamoud KA, Sadykov K, Nguyen BC, Laroche F, Feng H, Lee J, Pai SI, Varelas X, Egloff AM, Snyder-Cappione JE, Belkina AC,Bais MV, Monti S, Kukuruzinska MA. Functional and genomic analyses reveal therapeutic potential of targeting beta-catenin/CBP activity in head and neck cancer. Genome Med. 2018;10(1):54. Epub 2018/07/22. doi: 10.1186/s13073-018-0569-7. PubMed PMID: 30029671; PMCID: PMC6053793.
10.Trackman PC, Saxena D,Bais MV. TGF-beta1- and CCN2-Stimulated Sirius Red Assay for Collagen Accumulation in Cultured Cells. Methods Mol Biol. 2017;1489:481-5. Epub 2016/10/14. doi: 10.1007/978-1-4939-6430-7_39. PubMed PMID: 27734398.
11. Bais MV, Kukuruzinska M, Trackman PC. Corrigendum to “Orthotopic non-metastatic and metastatic oral cancer mouse models” [Oral Oncol. 51(5) (2015) 476-482]. Oral Oncol. 2017;72:201. Epub 2017/07/27. doi: 10.1016/j.oraloncology.2017.07.007. PubMed PMID: 28743466.
12.Bais MV, Goldring MB. LOXL2 as a protective in osteoarthritis cartilage. Aging (Albany NY). 2017;9(10):2024-5. Epub 2017/10/29. doi: 10.18632/aging.101317. PubMed PMID: 29080554; PMCID: PMC5680553.
13.Bais MV. Targeting oral cancer epigenome via LSD1. Aging (Albany NY). 2017;9(12):2455-6. Epub 2017/12/13. doi: 10.18632/aging.101343. PubMed PMID: 29232656; PMCID: PMC5764378.
14.Alshenibr W, Tashkandi MM, Alsaqer SF, Alkheriji Y, Wise A, Fulzele S, Mehra P, Goldring MB, Gerstenfeld LC,Bais MV. Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis. Arthritis Res Ther. 2017;19(1):179. Epub 2017/08/03. doi: 10.1186/s13075-017-1388-8. PubMed PMID: 28764769; PMCID: PMC5540418.
15.Alsaqer SF, Tashkandi MM, Kartha VK, Yang YT, Alkheriji Y, Salama A, Varelas X, Kukuruzinska M, Monti S,Bais MV. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget. 2017;8(43):73372-86. Epub 2017/11/02. doi: 10.18632/oncotarget.19637. PubMed PMID: 29088714; PMCID: PMC5650269.
16.Stanford EA, Ramirez-Cardenas A, Wang Z, Novikov O, Alamoud K, Koutrakis P, Mizgerd JP, Genco CA, Kukuruzinska M, Monti S,Bais MV, Sherr DH. Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis. Mol Cancer Res. 2016;14(8):696-706. Epub 2016/05/01. doi: 10.1158/1541-7786.MCR-16-0069. PubMed PMID: 27130942; PMCID: PMC4987205.
17.Ozdener GB,Bais MV, Trackman PC. Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide. Mol Oncol. 2016;10(1):1-23. Epub 2015/08/25. doi: 10.1016/j.molonc.2015.07.005. PubMed PMID: 26297052; PMCID: PMC4549800.
18.Alsulaiman M,Bais MV, Trackman PC. Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo. J Cell Commun Signal. 2016;10(1):17-31. Epub 2015/12/03. doi: 10.1007/s12079-015-0311-9. PubMed PMID: 26627907; PMCID: PMC4850135.
19.Hiemer SE, Zhang L, Kartha VK, Packer TS, Almershed M, Noonan V, Kukuruzinska M,Bais MV, Monti S, Varelas X. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma. Mol Cancer Res. 2015;13(6):957-68. Epub 2015/03/22. doi: 10.1158/1541-7786.MCR-14-0580. PubMed PMID: 25794680; PMCID: PMC4470857.
20.Bais MV, Ozdener GB, Sonenshein GE, Trackman PC. Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways. Oncogene. 2015;34(15):1928-37. Epub 2014/06/03. doi: 10.1038/onc.2014.147. PubMed PMID: 24882580; PMCID: PMC4254378.
21.Bais MV, Kukuruzinska M, Trackman PC. Orthotopic non-metastatic and metastatic oral cancer mouse models. Oral Oncol. 2015;51(5):476-82. Epub 2015/02/16. doi: 10.1016/j.oraloncology.2015.01.012. PubMed PMID: 25682387; PMCID: PMC4427342.
22.Khosravi R, Sodek KL, Xu WP,Bais MV, Saxena D, Faibish M, Trackman PC. A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia. PLoS One. 2014;9(6):e100669. Epub 2014/06/28. doi: 10.1371/journal.pone.0100669. PubMed PMID: 24971753; PMCID: PMC4074096 One. This does not alter the authors’ adherence to all of the PLOS One policies on sharing data and materials.
23.Bais M, Figee M, Denys D. Neuromodulation in obsessive-compulsive disorder. Psychiatr Clin North Am. 2014;37(3):393-413. Epub 2014/08/26. doi: 10.1016/j.psc.2014.06.003. PubMed PMID: 25150569.
24.Marsell R, Steen B,Bais MV, Mortlock DP, Einhorn TA, Gerstenfeld LC. Skeletal trauma generates systemic BMP2 activation that is temporally related to the mobilization of CD73+ cells. J Orthop Res. 2014;32(1):17-23. Epub 2013/09/11. doi: 10.1002/jor.22487. PubMed PMID: 24018651; PMCID: PMC4263190.
25.Eliades A, Papadantonakis N, Matsuura S, Mi R,Bais MV, Trackman P, Ravid K. Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide. Cell Cycle. 2013;12(8):1242-50. Epub 2013/03/23. doi: 10.4161/cc.24312. PubMed PMID: 23518500; PMCID: PMC3674089.
26.Bais MV, Nugent MA, Stephens DN, Sume SS, Kirsch KH, Sonenshein GE, Trackman PC. Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS One. 2012;7(2):e31188. Epub 2012/03/01. doi: 10.1371/journal.pone.0031188. PubMed PMID: 22363577; PMCID: PMC3280126.
27.Bais MV, Shabin ZM, Young M, Einhorn TA, Kotton DN, Gerstnefeld LC. Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. Biochem Biophys Res Commun. 2012;417(1):211-6. Epub 2011/12/07. doi: 10.1016/j.bbrc.2011.11.087. PubMed PMID: 22142851; PMCID: PMC3264057.
28.Iftikhar M, Hurtado P,Bais MV, Wigner N, Stephens DN, Gerstenfeld LC, Trackman PC. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation. J Biol Chem. 2011;286(2):909-18. Epub 2010/11/13. doi: 10.1074/jbc.M110.155622. PubMed PMID: 21071451; PMCID: PMC3020776.
29.Ravindra PV, Tiwari AK, Ratta B,Bais MV, Chaturvedi U, Palia SK, Sharma B, Chauhan RS. Time course of Newcastle disease virus-induced apoptotic pathways. Virus Res. 2009;144(1-2):350-4. Epub 2009/06/09. doi: 10.1016/j.virusres.2009.05.012. PubMed PMID: 19501124.
30.Bais M, McLean J, Sebastiani P, Young M, Wigner N, Smith T, Kotton DN, Einhorn TA, Gerstenfeld LC. Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes. PLoS One. 2009;4(5):e5393. Epub 2009/05/06. doi: 10.1371/journal.pone.0005393. PubMed PMID: 19415118; PMCID: PMC2673045.
31.Bais MV, Wigner N, Young M, Toholka R, Graves DT, Morgan EF, Gerstenfeld LC, Einhorn TA. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone. 2009;45(2):254-66. Epub 2009/04/29. doi: 10.1016/j.bone.2009.04.239. PubMed PMID: 19398045; PMCID: PMC2745982.
32.Bais MV, Kumar S, Tiwari AK, Kataria RS, Nagaleekar VK, Shrivastava S, Chindera K. Novel Rath peptide for intracellular delivery of protein and nucleic acids. Biochem Biophys Res Commun. 2008;370(1):27-32. Epub 2008/03/19. doi: 10.1016/j.bbrc.2008.03.023. PubMed PMID: 18346454.
33.Nagaleekar VK, Tiwari AK, Kataria RS,Bais MV, Ravindra PV, Kumar S. Bluetongue virus induces apoptosis in cultured mammalian cells by both caspase-dependent extrinsic and intrinsic apoptotic pathways. Arch Virol. 2007;152(9):1751-6. Epub 2007/05/29. doi: 10.1007/s00705-007-0988-z. PubMed PMID: 17530353.
34.Bais MV, Kataria RS, Tiwari AK, Viswas KN, Reddy AV, Prasad N. Sequence analysis of an Indian field isolate of infectious bursal disease virus shows six unique amino acid changes in the VP1 gene. Vet Res Commun. 2004;28(7):641-6. Epub 2004/11/26. doi: 10.1023/b:verc.0000042876.09951.b2. PubMed PMID: 15563111.
35.Indervesh, Tiwari AK, Kataria RS, Viswas KN,Bais MV, Suryanarayana VV. Isolates of infectious bursal disease virus from India are of very virulent phenotype. Acta Virol. 2003;47(3):173-7. Epub 2003/12/09. PubMed PMID: 14658846.
36.Bais MV, Kataria RS, Tiwari AK, Indervesh, Suryanarayana VV, Das SK. Sequence analysis of segment a of a field virus isolate from an outbreak of Infectious bursal disease in India. Acta Virol. 2003;47(2):73-7. Epub 2003/10/04. PubMed PMID: 14524472.
